Patents Assigned to BOREAN PHARMA APS
  • MULTIMERISED HIV FUSION INHIBITORS
    Publication number: 20100048879
    Abstract: There are provided multimeric fusion proteins exhibiting anti-viral activity. The fusion proteins comprise the HR2 region of the ectodomain of the human immunodeficiency virus gp41 protein which is fused to a multimerisation domain peptide such as a trimerisation domain derived from tetranectin. The multimerised fusion proteins may be used as HIV fusion inhibitors in the treatment of AIDS.
    Type: Application
    Filed: January 16, 2008
    Publication date: February 25, 2010
    Applicant: BOREAN PHARMA APS
    Inventor: Michael ETZERODT